|
Piramal Pharma Ltd eases for fifth straight session> |
|
Piramal Pharma to convene board meeting> |
|
Piramal Pharma’s Lexington facility receives four USFDA observations> |
|
Piramal Pharma Ltd down for fifth straight session> |
|
Piramal Pharma Ltd - Piramal Pharma Limited - Analysts/Institutional Investor Meet/Con. Call Updates> |
|
Piramal Pharma reports consolidated net loss of Rs 99.22 crore in the September 2025 quarter> |
|
Benchmarks trade in negative terrain; realty shares decline for 2nd day> |
|
Piramal Pharma reports dismal Q2 numbers> |
|
Piramal Pharma Ltd - Piramal Pharma Limited - Analysts/Institutional Investor Meet/Con. Call Updates> |
|
Piramal Pharma Ltd - Piramal Pharma Limited - Analysts/Institutional Investor Meet/Con. Call Updates> |